Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Transplantation Proceedings
Journal
Overview
Identity
Overview
Publication Venue For
Lung Transplantation for Cystic Fibrosis and Non-cystic Fibrosis Bronchiectasis: A Single-Center Experience
. 51:2029-2034.
2019
Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report
. 48:3099-3105.
2016
Recurrent IgA Nephropathy After Kidney Transplantation
. 48:2689-2694.
2016
Falsely incompatible b-cell flow cytometry crossmatch after pronase treatment: A case report
. 47:831-833.
2015
Survey of First-Year Medical Students to Assess Their Knowledge and Attitudes Toward Organ Transplantation and Donation
. 41:634-638.
2009
Can Machine Perfusion Decrease the Likelihood of Discard Among Biopsied Kidneys?
. 40:1029-1031.
2008
A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients
. 37:4303-4305.
2005
Preformed antibodies to α1,3-galactosyltransferase gene-knockout (GT-KO) pig cells in humans, baboons, and monkeys: Implications for xenotransplantation
. 37:3514-3515.
2005
A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: The cincinnati experience
. 37:802-803.
2005
Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression
. 37:800-801.
2005
Chemotherapy for posttransplant lymphoproliferative disorder: The Israel Penn International Transplant Tumor Registry Experience
. 37:956-957.
2005
Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy
. 37:795-797.
2005
De novo colorectal cancer: Five-year survival is markedly lower in transplant recipients compared with the general population
. 37:960-961.
2005
Donor kidneys with small renal cell cancers: Can they be transplanted?
. 37:581-582.
2005
Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: Multivariate analysis of risk factors for acute rejection
. 37:798-799.
2005
Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis
. 37:817-818.
2005
Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation
. 37:812-813.
2005
Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens
. 37:809-811.
2005
Laparoscopic living donor nephrectomy for kidneys with multiple arteries
. 37:629-630.
2005
Laparoscopic right living donor nephrectomy
. 37:631-632.
2005
Methicillin-resistant Staphylococcus aureus infection in liver transplantation: A matched controlled study
. 37:1243-1244.
2005
Pilot study of early corticosteroid elimination after pancreas transplantation
. 37:1287-1288.
2005
Posttransplant lymphoproliferative disorder: Significance of central nervous system involvement
. 37:954-955.
2005
Potential of aspirin to inhibit thrombotic microangiopathy in α1,3-galactosyltransferase gene-knockout pig hearts after transplantation in baboons
. 37:489-490.
2005
Prostate cancer prior to solid organ transplantation: The Israel Penn International Transplant Tumor Registry Experience
. 37:958-959.
2005
Skin cancer following transplantation: The Israel Penn International Transplant Tumor Registry experience
. 37:962-963.
2005
Limited engraftment capacity of bone marrow-derived mesenchymal cells in xenogeneic bone marrow transplantation
. 35:504-505.
2003
Depletion of natural anti-pig antibodies by the continuous infusion of oligosaccharides in a pig-to-baboon model
. 34:2757-2758.
2002
The role of mouse stroma in rat haematopoiesis in xenogeneic rat/mouse bone marrow transplantation chimeras
. 34:2759.
2002
De novo breast cancer in renal transplant recipients
. 34:1778-1779.
2002
De novo sarcomas in solid organ transplant recipients
. 34:1786-1787.
2002
Delay of hepatitis C recurrence in liver transplant recipients: Impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction
. 34:1561-1562.
2002
Gastric cancer in transplant recipients: Detection of malignacy by aggressive endoscopy
. 34:1784-1785.
2002
Immunosuppression and merkel cell cancer
. 34:1780-1781.
2002
Impact of noncompliance and donor/recipient race matching on chronic liver rejection
. 34:1497-1498.
2002
Is there a need for surveillance endomyocardial biopsies in heart transplantation?
. 34:1857-1859.
2002
Polyomavirus in kidney and kidney-pancreas transplantation: A defined protocol for immunosuppression reduction and histologic monitoring
. 34:1788-1789.
2002
Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil
. 34:1563-1564.
2002
Transplantation without steroids
. 34:2076-2078.
2002
Biologic behavior of carcinoid tumors in solid organ transplant recipients: The Israel Penn international transplant tumor registry experience
. 33:3656-3657.
2001
Kaposi sarcoma: An analysis of the US and international experiences from the Israel Penn international transplant tumor registry
. 33:3660-3661.
2001
Effects of xenogeneic thymic transplantation in baboons
. 33:766.
2001
Miniature swine and hDAF pig kidney transplantation in baboons treated with a nonmyeloablative regimen and CD154 blockade
. 33:716.
2001
A nonmyeloablative regimen with CD40L blockade leads to humoral and cellular hyporesponsiveness to pig hematopoietic cells in baboons
. 32:1100.
2000
Coagulation/thrombotic disorders associated with organ and cell xenotransplantation
. 32:1099.
2000
Effect of B cell/plasma cell depletion or suppression on Anti-Gal antibody in the baboon
. 32:1009.
2000
Experience with porcine thymic transplantation in baboons
. 32:1048.
2000
Increases in autologous hematopoietic progenitors in the blood of baboons following irradiation and treatment with porcine stem cell factor and interleukin-3
. 32:1045-1046.
2000
Induction of mixed hematopoietic chimerism in the pig-to-baboon model
. 32:1101.
2000
Injection of porcine anti-idiotypic antibodies to primate anti-Gal antibodies leads to active inhibition of serum cytotoxicity in a baboon
. 32:1102.
2000
Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody: Experience with 275 aphereses in baboons
. 32:860.
2000
Von willebrand factor concentration, multimeric patterns, and cleaving protease activity in baboons undergoing xenogeneic peripheral blood stem cell transplantation
. 32:990.
2000
Xenogeneic and allogeneic skin grafting after retrovirus-mediated SLA Class II DR gene transfer in baboons
. 32:289-290.
2000
Erratum: Potential utility of rapamycin and tacrolimus in long-term, low-toxicity regimens (Transplantation Proceedings Vol. 31 (Suppl. 8A) (1999) (17S-22S))
. 32:503-504.
2000
Construction of a recombinant adenovirus vector encoding Fas ligand with a CRE/Loxp inducible system
. 31:792-793.
1999
Physiologic changes following brain death
. 31:1001-1002.
1999
Potential utility of rapamycin and tacrolimus in long-term, low-toxicity regimens
. 31:17-22.
1999
Xenogeneic thymic transplantation in a pig-to-nonhuman primate model
. 31:957.
1999
The safety of xenotransplantation
. 30:2461-2462.
1998
Race is not a critical factor in orthotopic liver transplantation.
. 29:3729-3730.
1997
Recurrent or persistent cardiac allograft rejection: therapeutic options and recommendations.
. 29:40S-44S.
1997
Renal transplantation in African-American recipients: three decades at a single center.
. 29:3726-3728.
1997
Molecular screening of xenodonor genomes for species-specific endogenous retroviral DNA sequences
. 29:897-898.
1997
Recurrent or persistent cardiac allograft rejection: Therapeutic options and recommendations
. 29:40S-44S.
1997
Molecular conjugate-mediated gene transfer in renal transplantation
. 28:2046-2048.
1996
Class I and class II antigens in the rejection of murine islet cell transplants
. 27:3234-3235.
1995
Functional effects of transplanted human fetal ventral mesencephalic brain tissue from spontaneous abortions into a rodent model of Parkinson's disease
. 26:3335.
1994
RS-61443: A new immunosuppressive agent
. 26:3144-3146.
1994
Effects of total parenteral nutrition on intestinal morphology and function in humans
. 26:1457.
1994
Is xenotransplantation a realistic clinical option?
. 24:2393-2396.
1992
Recent advances in the identification of significant human cytomegalovirus-encoded proteins.
. 23:64-69.
1991
Are black living-related renal donors at greater long-term risk of renal complications than white donors?
. 23:1328-1329.
1991
Comparison of simple hypothermic storage, pulsatile perfusion with Belzer's gluconate-albumin solution, and pulsatile perfusion with UW solution for renal allograft preservation
. 23:2394-2395.
1991
Limitation of free radical injury by reduced glutathione: An effective means of improving the recovery of heart transplants
. 23:2440-2442.
1991
Accelerated cardiac allograft rejection associated with administration of liver cell extract in the baboon
. 22:1966-1969.
1990
Age: A major determinant of renal dysfunction
. 22:365-367.
1990
Effect of pharmacologic immunosuppression on donor heart survival in a closely related nonhuman primate xenograft model
. 22:1086-1087.
1990
Pulsatile perfusion preservation: Early posttransplant dialysis requirement predicts rapid graft loss
. 22:446-447.
1990
The exocrine secretions of the grafted pancreas
. 21:3449-3451.
1989
Can cardiac allografts and xenografts be transplanted across the ABO blood group barrier?
. 21:549-550.
1989
Can cardiac allografts and xenografts be transplanted across the ABO blood group barrier?
. 21:549-550.
1989
Diagnosis of acute cardiac rejection by changes in left ventricular volumes.
. 21:2533.
1989
A parametric analysis of the hazard of cancer after transplantation
. 21:3201-3204.
1989
Diagnosis of acute cardiac rejection by changes in left ventricular volumes
. 21:2533.
1989
Early extranuclear effect of triiodothyronine (T3) on tissue slices: Relevance to organ donor viability
. 21:1263-1264.
1989
Early graft function in primary and regraft recipients of paired cadaveric kidneys
. 21:1274-1275.
1989
Electrocardiographic and histopathologic changes developing during experimental brain death in the baboon
. 21:2567-2569.
1989
Lymphocytic IgM antibody in highly sensitized (>50% PRA) autologous negative renal allograft candidates
. 21:739-741.
1989
Successful renal allografts in recipients with a positive standard, DTE negative cross-match
. 21:746-747.
1989
Sustained high panel reactive antibody levels in highly sensitized patients: Significance of continued transfusions
. 21:771-772.
1989
Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients
. 21:1787-1789.
1989
Added effects of organ (heart) storage after brain death in the experimental animal
. 20:39-43.
1988
Effects of hormonal therapy on subsequent organ (kidney) storage in the experimental animal
. 20:55-58.
1988
Endocrine changes and metabolic responses
. 20:33-38.
1988
Hemodynamic and electrocardiographic responses
. 20:25-28.
1988
Hormonal therapy in the brain-dead experimental animal
. 20:51-54.
1988
Myocardial and pulmonary histopathologic changes
. 20:29-32.
1988
Results of hormonal therapy in human brain-dead potential organ donors
. 20:59-62.
1988
Induction of suppressor T cells by cytokines
. 20:1156-1157.
1988
Added effects of organ (heart) storage after brain death in the experimental animal.
. 20:39-43.
1988
Effects of hormonal therapy on subsequent organ (kidney) storage in the experimental animal.
. 20:55-58.
1988
Endocrine changes and metabolic responses.
. 20:33-38.
1988
Hemodynamic and electrocardiographic responses.
. 20:25-28.
1988
Hormonal therapy in the brain-dead experimental animal.
. 20:51-54.
1988
Myocardial and pulmonary histopathologic changes.
. 20:29-32.
1988
Results of hormonal therapy in human brain-dead potential organ donors.
. 20:59-62.
1988
Cyclosporine impairs the renal response to volume depletion
. 20:568-571.
1988
Cyclosporine neurotoxicity in liver transplant recipients: Report of three cases
. 20:116-118.
1988
Early graft loss in cyclosporine A-treated cadaveric renal allograft recipients receiving retransplants against previous mismatched HLA-A, -B, -DR donor antigens
. 20:170-172.
1988
Preservation by pulsatile perfusion improves early renal allograft function
. 20:865-868.
1988
The physiological management of cardiac transplant donors and recipients using triiodothyronine
. 20:803-805.
1988
Triiodothyronine therapy in the cardiac transplant recipient
. 20:65-68.
1988
Brain death, triiodothyronine depletion, and inhibition of oxidative phosphorylation: Relevance to management of organ donors
. 19:4110-4111.
1987
Is ABO compatibility essential in xenografting between closely related species?
. 19:4437-4440.
1987
Prolongation of cardiac xenograft (vervet monkey to baboon) function by a combination of total lymphoid irradiation and immunosuppressive drug therapy
. 19:4441-4442.
1987
Virological implications of the use of primates in xenotransplantation
. 19:4068-4069.
1987
Cardiac allograft survival in ABO blood group incompatible baboons
. 19:1036-1038.
1987
Cardiac transplantation using discordant xenografts in a nonhuman primate model
. 19:1153-1154.
1987
Unusual functional and biochemical properties of DR molecules from the HLA-DR1, B14 haplotype
. 19:851-857.
1987
Cardiac allograft survival in ABO blood group incompatible baboons.
. 19:1036-1038.
1987
Cardiac transplantation using discordant xenografts in a nonhuman primate model.
. 19:1153-1154.
1987
Quadruple immunosuppressive therapy in whole pancreas transplantation.
. 19:2297-2299.
1987
Quadruple therapy for cadaver renal transplantation.
. 19:1917-1919.
1987
Unusual functional and biochemical properties of DR molecules from the HLA-DR1, B14 haplotype.
. 19:851-857.
1987
A technique for transplantation of a large adult kidney into an infant
. 19:2953-2955.
1987
Are there indications for heterotopic heart transplantation today?
. 19:2512-2513.
1987
The value of hormonal therapy in improving organ viability in the transplant donor.
. 19:2037-2038.
1987
Brain death-induced hemodynamic changes resulting in cardiac and pulmonary injury in the baboon
. 18:1190-1192.
1986
Cadaver donor renal transplantation in insulin-dependent diabetics using cyclosporine and antilymphoblast globulin
. 18:1720-1723.
1986
Evidence of myocardial and renal functional recovery following hormonal treatment after brain death
. 18:613-615.
1986
Hemodynamic changes, myocardial injury, and pulmonary edema induced by sympathetic activity during the development of brain death in the baboon
. 18:609-612.
1986
Improved function of stored hearts following hormonal therapy after brain death in pigs
. 18:1419-1421.
1986
Sequential antilymphocyte globulin cyclosporine therapy in cadaver renal transplantation
. 18:16-18.
1986
Two haplotype mismatched live donor renal transplantation in diabetics
. 18:1730-1732.
1986
Analysis of flow cytometry and cytotoxicity crossmatches in renal transplantation
. 17:2480-2481.
1985
Effects of brain death and hypothermic perfusion storage on donor heart function: An experimental study
. 17:231-232.
1985
HLA restriction patterns of trinitrophenyl-specific proliferative human T cell clones
. 17:972-977.
1985
Prediction of acute cardiac rejection using radionuclide scanning to detect left ventricular volume changes
. 17:218-220.
1985
Use of cell line K562 and autologous B lymphoblastoid cell lines to identify and remove autoantibodies from the serum of renal patients
. 17:171-173.
1985
Heterotopic versus orthotopic heart transplantation
. 16:886-892.
1984
Correlation of B-cell antibodies and clinical course in DRw-typed renal allograft recipients
. 13:942-944.
1981
The quality of life after liver transplantation
. 11:252-256.
1979
Outcome of renal transplantation in patients with primary cytomegalovirus infection
. 11:1288-1290.
1979
Suppressor T cells in the regulation of immune responses to allogeneic tissues
. 10:19-22.
1978
Early recognition of chronic humoral rejection in long-term follow-up of kidney recipients by a comprehensive renal radionuclide study.
. 9:43-47.
1977
Serologic detection of antigens controlled by the Ir region of the H-2 complex in the mouse.
. 5:1811-1813.
1973
Identity
International Standard Serial Number (issn)
0041-1345
Electronic International Standard Serial Number (eissn)
1873-2623